Treatment of cardiomyopathy
US5798102A · kind A · utility
30Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 1997 |
| Grant date | Aug 25, 1998 |
| Priority date | — |
| Expiry date | Mar 4, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention presents methods for the treatment of symptoms associated with cardiomyopathy comprising treatment with an effective amount of a composition comprising beta-amyloid, streptolysin O, and growth hormone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.